chloramphenicol 250mg capsules
essential generics ltd - chloramphenicol - oral capsule - 250mg
viceton- chloramphenicol tablet, coated
bimeda, inc. - chloramphenicol (unii: 66974fr9q1) (chloramphenicol - unii:66974fr9q1) - chloramphenicol 250 mg - indications : chloramphenicol tablets are recommended for oral treatment of the following conditions in dogs: - bacterial pulmonary infections caused by susceptible microorganisms such as: staphylococcus aureus , streptococcus pyogenes and brucella bronchiseptica . - infections of the urinary tract caused by susceptible microorganisms such as: escherichia coli , proteus vulgaris , corynebacterium renale , streptococcus spp., and hemolytic staphylococcus . - enteritis caused by susceptible microorganisms such as: e. coli , proteus spp., salmonella spp., and pseudomonas spp. - infections associated with canine distemper caused by susceptible microorganisms such as: b. bronchiseptica , e. coli , p. aeruginosa , proteus spp., shigella spp. and neisseria catarrhalis . additional adjunctive therapy should be used when indicated. most susceptible infectious disease organisms will respond to chloramphenicol therapy in three to five days when the recommended dosage regimen is followed. if no response to chloram
chloromycetin- chloramphenicol ointment
parke-davis - chloramphenicol (unii: 66974fr9q1) (chloramphenicol - unii:66974fr9q1) - ointment - chloramphenicol should be used only in those serious infections for which less potentially dangerous drugs are ineffective or contraindicated. bacteriological studies should be performed to determine the causative organisms and their sensitivity to chloramphenicol (see boxed warning). chloromycetin ophthalmic ointment, 1% (chloramphenicol ophthalmic ointment, usp) is indicated for the treatment of surface ocular infections involving the conjunctiva and/or cornea caused by chloramphenicol-susceptible organisms. the particular antiinfective drug in this product is active against the following common bacterial eye pathogens: staphylococcus aureus streptococcus , including streptococcus pneumoniae escherichia coli haemophilus influenzae klebsiella/enterobacter species moraxella lucunata (morax-axenfeld bacillus) neisseria species this product does not provide adequate coverage against: pseudomonas aeruginosa serratia marcescens this product is contraindicated in persons sensitive to any of its components.
chloropt p eye ointment chloramphenicol polymixin
ceva animal health pty ltd - chloramphenicol; polymyxin b sulfate - misc. aural, ophthalmic, oro/naso pharyngeal - chloramphenicol antibiotic active 10.0 mg/g; polymyxin b sulfate antibiotic active 0.8 mg/g - ophthalmic preparations - cat | dog | bitch | castrate | cat - queen | cat - tom | kitten | puppy - infection - ocular | eye infections | ocular infections
chloramphenicol powder
ax pharmaceutical corp - chloramphenicol (unii: 66974fr9q1) (chloramphenicol - unii:66974fr9q1) -
chloramphenicol powder
ax pharmaceutical corp - chloramphenicol (unii: 66974fr9q1) (chloramphenicol - unii:66974fr9q1) -
chloromycetin succinate injection powder for solution
searchlight pharma inc - chloramphenicol (chloramphenicol sodium succinate) - powder for solution - 1g - chloramphenicol (chloramphenicol sodium succinate) 1g - chloramphenicol
chloramphenicol solution
pharma stulln inc. - chloramphenicol - solution - 0.5% - chloramphenicol 0.5% - antibacterials
synthomycine 3 %
teva israel ltd - chloramphenicol - ointment - chloramphenicol 3 % - chloramphenicol - chloramphenicol - antibiotic.
chloramphenicol ointment
pharma stulln inc. - chloramphenicol - ointment - 1% - chloramphenicol 1% - antibacterials